Cordis, Abbott Continue Battle Over Stent Patents

Law360, New York (June 13, 2007, 12:00 AM EDT) -- Johnson & Johnson subsidiary Cordis Corp. has struck the most recent blow in its battle with Abbott Laboratories over the $2 billion annual U.S. market for drug-eluting coronary stents, filing a infringement suit against Abbott based on a patent that was issued Tuesday.

Cordis Corp. filed the lawsuit on Monday, in federal court in New Jersey, naming Abbott as the sole defendant. Tuesday, Abbott asked a Delaware court for permission to add Cordis' new patent to a declaratory judgment suit Abbott filed in 2006.

Cordis and...
To view the full article, register now.